Currently out of the existing stock ratings of Michael Okunewitch, 1 are a HOLD (20%), 4 are a BUY (80%).

Michael Okunewitch

Work Performance Price Targets & Ratings Chart

Analyst Michael Okunewitch, currently employed at MAXIM GROUP,

Michael Okunewitch’s has documented 10 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on KPRX, Kiora Pharmaceuticals at 09-Aug-2023.

Wall Street Analyst Michael Okunewitch

Analyst best performing recommendations are on KPRX (KIORA PHARMACEUTICALS).
ATAI ATAI Life Sciences BV CTXR Citius Pharmaceuticals KPRX Kiora Pharmaceuticals BRTX BioRestorative Therapies

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$15

$13.92 (1288.89%)

$15

2 months 9 days ago
(30-Aug-2024)

0/6 (0%)

$13.7 (1053.85%)

Buy

$9

$7.92 (733.33%)

1 years 5 months 27 days ago
(12-May-2023)

0/3 (0%)

$7.1 (373.68%)

Buy

1 years 7 months 12 days ago
(27-Mar-2023)

0/1 (0%)

$17.08 (114.48%)

Buy

$28

2 years 7 months 7 days ago
(01-Apr-2022)

0/2 (0%)

$16.83 (150.67%)

Hold

$9

$7.92 (733.33%)

$17

2 years 7 months 8 days ago
(31-Mar-2022)

0/3 (0%)

$3.91 (76.82%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Michael Okunewitch?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?